Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Eli Lilly & CO Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

$3.1 Billion
Q3 2024

A detailed history of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H transactions in Eli Lilly & CO stock. As of the latest transaction made, Meag Munich Ergo, Kapitalanlagegesellschaft Mb H holds 64,775 shares of LLY stock, worth $48.6 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares

64,775

Previous 63,161 2.56%

Holding current value

$48.6 Million

Previous $57.2 Million 0.35%

% of portfolio

1.85%

Previous 1.94%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$772.14 - $960.02 $1.25 Million - $1.55 Million	1,614 Added 2.56%	64,775 $57.4 Million
Q2 2024 Aug 01, 2024	BUY	$724.87 - $909.04 $3.49 Million - $4.38 Million	4,819 Added 8.26%	63,161 $57.2 Million
Q1 2024 Apr 18, 2024	SELL	$592.2 - $792.28 $7.29 Million - $9.76 Million	-12,316 Reduced 17.43%	58,342 $45.4 Million
Q4 2023 Jan 19, 2024	BUY	$525.19 - $619.13 $1.24 Million - $1.47 Million	2,368 Added 3.47%	70,658 $41.2 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $3.43 Million - $4.73 Million	7,894 Added 13.07%	68,290 $36.7 Million
Q2 2023 Jul 14, 2023	SELL	$350.74 - $468.98 $46.6 Million - $62.4 Million	-132,982 Reduced 68.77%	60,396 $28.3 Million
Q1 2023 Apr 20, 2023	BUY	$310.63 - $364.82 $7.37 Million - $8.66 Million	23,729 Added 13.99%	193,378 $66.4 Million
Q4 2022 Jan 19, 2023	SELL	$321.55 - $374.67 $7.93 Million - $9.24 Million	-24,654 Reduced 12.69%	169,649 $62.1 Million
Q3 2022 Oct 18, 2022	BUY	$296.48 - $337.87 $4.4 Million - $5.01 Million	14,833 Added 8.26%	194,303 $62.8 Million
Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $12.6 Million - $14.8 Million	45,229 Added 33.69%	179,470 $58.2 Million
Q1 2022 Apr 13, 2022	BUY	$234.69 - $291.66 $4.88 Million - $6.07 Million	20,806 Added 18.34%	134,241 $38.9 Million
Q4 2021 Jan 25, 2022	BUY	$224.85 - $279.04 $17.9 Million - $22.2 Million	79,618 Added 235.44%	113,435 $31.6 Million
Q3 2021 Oct 13, 2021	BUY	$221.6 - $272.71 $422,369 - $519,785	1,906 Added 5.97%	33,817 $7.81 Million
Q2 2021 Jul 16, 2021	BUY	$180.55 - $233.54 $5.76 Million - $7.45 Million	31,911 New	31,911 $7.32 Million
Q1 2020 Apr 23, 2020	SELL	$119.05 - $147.35 $1.56 Million - $1.93 Million	-13,114 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $4.74 Million - $5.87 Million	-44,294 Reduced 77.16%	13,114 $1.72 Million
Q3 2019 Oct 29, 2019	BUY	$106.79 - $116.16 $2.3 Million - $2.51 Million	21,580 Added 60.23%	57,408 $6.42 Million
Q1 2019 Apr 29, 2019	BUY	$111.31 - $131.02 $3.99 Million - $4.69 Million	35,828 New	35,828 $4.62 Million
Q4 2018 Jan 29, 2019	SELL	$105.9 - $118.64 $4.57 Million - $5.12 Million	-43,135 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$85.86 - $107.31 $4.98 Million - $6.22 Million	-57,988 Reduced 57.34%	43,135 $4.58 Million
Q2 2018 Jul 17, 2018	SELL	$75.7 - $86.88 $3.69 Million - $4.23 Million	-48,712 Reduced 32.51%	101,123 $8.72 Million
Q1 2018 May 02, 2018	BUY	$74.21 - $87.6 $2.04 Million - $2.41 Million	27,533 Added 22.51%	149,835 $11.5 Million
Q4 2017 Jan 26, 2018	SELL	$81.94 - $87.89 $1.25 Million - $1.34 Million	-15,281 Reduced 11.11%	122,302 $10.5 Million
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $10.6 Million - $11.8 Million	137,583	137,583 $11.7 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Account

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Eli Lilly & CO Transaction History